U.S. markets open in 9 hours 17 minutes
  • S&P Futures

    3,644.75
    -9.50 (-0.26%)
     
  • Dow Futures

    29,185.00
    -100.00 (-0.34%)
     
  • Nasdaq Futures

    11,195.50
    -32.75 (-0.29%)
     
  • Russell 2000 Futures

    1,676.40
    -5.70 (-0.34%)
     
  • Crude Oil

    80.88
    -0.35 (-0.43%)
     
  • Gold

    1,669.60
    +1.00 (+0.06%)
     
  • Silver

    18.82
    +0.10 (+0.55%)
     
  • EUR/USD

    0.9803
    -0.0016 (-0.17%)
     
  • 10-Yr Bond

    3.7470
    +0.0420 (+1.13%)
     
  • Vix

    31.84
    +1.66 (+5.50%)
     
  • GBP/USD

    1.1090
    -0.0033 (-0.30%)
     
  • USD/JPY

    144.7060
    +0.2630 (+0.18%)
     
  • BTC-USD

    19,401.14
    -110.29 (-0.57%)
     
  • CMC Crypto 200

    443.42
    -2.56 (-0.57%)
     
  • FTSE 100

    6,881.59
    -123.80 (-1.77%)
     
  • Nikkei 225

    25,886.45
    -535.60 (-2.03%)
     

Medtronic Receives FDA Clearance For First Insertable Cardiac Monitor Indication For Pediatric Patients

·1 min read
  • The FDA granted 510(k) clearance to Medtronic plc's (NYSE: MDT) LINQ II Insertable Cardiac Monitor (ICM) system for use in pediatric patients over the age of 2 who have heart rhythm abnormalities and require long-term, continuous monitoring.

  • The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population.

  • Also Read: Medtronic Recalls HeartWare HVAD System Batteries For Electrical Faults.

  • The LINQ II system is a small (one-third the size of a AAA battery) wireless ICM for patients with abnormal heart rhythms who experience infrequent symptoms.

  • The LINQ II ICM, which has a battery life of up to 4.5 years, allows patients to undergo magnetic resonance imaging (MRI) when needed and does not interfere with daily activities.

  • The LINQ II ICM system also includes the recently launched AccuRhythm AI algorithms.

  • The two AI algorithms have been shown to reduce the number of false alerts specific to the most common ICM false alerts while preserving more than 99% of true alerts.

  • Price Action: MDT shares are down 0.96% at $88.82 on the last check Tuesday.

  • Photo via Company

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.